Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The pathogenesis of, and pharmacological treatment for, Canavan disease

Drug Discovery Today(2022)10.1016/j.drudis.2022.05.019Source: DataRank Database

The pathogenesis of, and pharmacological treatment for, Canavan disease is a research paper published in Drug Discovery Today (2022). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

Linked data & code

omim

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: greenTopics (11)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

John R. Moffett ORCID,Man Amanat,Ali Fatemi ORCID,Takashi Tsukamoto ORCID,Aryan M.A. Namboodiri

Live enrichment

PubMed:35636725 PMC:PMC11806932

National Institutes of Health

Grant: NS 084206

National Institutes of Health

Grant: NS 39387

National Institutes of Health

Grant: 1R61NS119659

NINDS NIH HHS

Grant: R21 NS084206

NINDS NIH HHS

Grant: R61 NS119659

NINDS NIH HHS

Grant: R61 NS136652

NINDS NIH HHS

Grant: R56 NS039387

NINDS NIH HHS

Grant: R33 NS119659

NINDS NIH HHS

Grant: R01 NS039387

Uniformed Services University of the Health Sciences

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11806932

publisherhttps://api.elsevier.com/content/article/PII:S1359644622002112?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1359644622002112?httpAccept=text/plain

MeSH Terms

BrainOligodendrogliaAnimalsCanavan DiseaseDisease Models, AnimalAmidohydrolases

Keywords

N-acetylaspartate (Naa)Nadc3Canavan Disease (Cd)Aspartate N-acetyltransferase (Asp-nat)Aspartoacylase (Aspa)

Related Papers (2)

Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation

N/A

1.6DataRank · unranked

eLife(2021)

co-cited

10.7554/elife.60311

Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism

N/A

0.360DataRank · unranked

Progress in Neurobiology(2023)

co-cited

10.1016/j.pneurobio.2023.102460

The pathogenesis of, and pharmacological treatment for, Canavan disease

FAIR Checklist

Authors (7)

Funding (10 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)